Literature DB >> 17080016

The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo.

S Ivankovic1, R Stojkovic, M Jukic, M Milos, M Milos, M Jurin.   

Abstract

AIM: The aim of the study was to investigate antitumor activity of thymoquinone (TQ) and thymohydroquinone (THQ) in vitro and in vivo.
MATERIALS AND METHODS: In the in vitro experiments, L929 mouse broblasts and two tumor cell lines (squamous cell carcinoma (SCC VII) and fibrosarcoma (FsaR)) were used. The cells were cultured with 0.1 or 0.01 mg/ml TQ or THQ for 24 h, and cytotoxicity assay was performed with the use of crystal violet staining technique. For in vivo antitumor efficiency evaluation of new compounds two murine tumor models (fibrosarcoma (FsaR) and squamous cell carcinoma (SCC VII)) were used. The used dose was equal for both substances. Antitumor effect of 4 intratumoral injections of TQ and THQ at the dose of 5 mg/kg was evaluated by comparison of tumor growth kinetics between treated and control animals.
RESULTS: In vitro study showed that TQ and THQ exhibit statistically significant cytotoxic activity (p less, similar 0.01). The cytotoxic activity was dose dependent and more expressed against tumor cells than against L929 fibroblasts. The result of antitumor activities of TQ and THQ in vivo reached TGI = 52% and it was statistically significant (p less, similar 0.05).
CONCLUSION: The results indicate that THQ antitumor activity may be improved with further dose increase of the investigated substance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080016

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  23 in total

Review 1.  Review on molecular and therapeutic potential of thymoquinone in cancer.

Authors:  Sanjeev Banerjee; Subhash Padhye; Asfar Azmi; Zhiwei Wang; Philip A Philip; Omer Kucuk; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.

Authors:  Maria P Torres; Moorthy P Ponnusamy; Subhankar Chakraborty; Lynette M Smith; Srustidhar Das; Hwyda A Arafat; Surinder K Batra
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

3.  Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway.

Authors:  Jing Yang; Xiang-ru Kuang; Ping-tian Lv; Xi-xin Yan
Journal:  Tumour Biol       Date:  2014-09-20

4.  Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation.

Authors:  Kaouther Kolli-Bouhafs; Abdelaziz Boukhari; Abdurazzag Abusnina; Emilie Velot; Jean-Pierre Gies; Claire Lugnier; Philippe Rondé
Journal:  Invest New Drugs       Date:  2011-12-15       Impact factor: 3.850

5.  Proapoptotic and antimetastatic properties of supercritical CO2 extract of Nigella sativa Linn. against breast cancer cells.

Authors:  Hussein M Baharetha; Zeyad D Nassar; Abdalrahim F Aisha; Mohamed B Khadeer Ahamed; Foaud Saleih R Al-Suede; Mohd Omar Abd Kadir; Zhari Ismail; Amin Malik Shah Abdul Majid
Journal:  J Med Food       Date:  2013-12       Impact factor: 2.786

6.  From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond.

Authors:  Subhash Padhye; Sanjeev Banerjee; Aamir Ahmad; Ramzi Mohammad; Fazlul H Sarkar
Journal:  Cancer Ther       Date:  2008

7.  Antiproliferative and Apoptosis-Inducing Activities of Thymoquinone in Lymphoblastic Leukemia Cell Line.

Authors:  Amin Soltani; Batoul Pourgheysari; Hedayatollah Shirzad; Zahra Sourani
Journal:  Indian J Hematol Blood Transfus       Date:  2016-12-08       Impact factor: 0.900

Review 8.  Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.

Authors:  Omeima Abdullah; Ziad Omran; Salman Hosawi; Ali Hamiche; Christian Bronner; Mahmoud Alhosin
Journal:  Genes (Basel)       Date:  2021-04-22       Impact factor: 4.096

9.  Combinatorial Effects of Thymoquinone on the Anticancer Activity and Hepatotoxicity of the Prodrug CB 1954.

Authors:  Wamidh H Talib; Majed M Abukhader
Journal:  Sci Pharm       Date:  2013-01-03

10.  Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma.

Authors:  Subhasis Das; Kaushik Kumar Dey; Goutam Dey; Ipsita Pal; Abhijit Majumder; Sujata MaitiChoudhury; Subhas C kundu; Mahitosh Mandal
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.